About BARD Peripheral Vascular
BARD Peripheral Vascular is a company based in Tempe (United States) founded in 1974. BARD Peripheral Vascular operates in a competitive market with competitors including Inari Medical, W. L. Gore & Associates, Contego Medical, Echopoint Medical and Limflow, among others.
- Headquarter Tempe, United States
- SectorsHealthcare
- Website bardpv.com
- Social LinkedIn X YouTube
Apps and channels of BARD Peripheral Vascular
its YouTube channel BD has 33.8K subscribers and 30 videos.
Videos from BARD Peripheral Vascular
The most watched videos on BARD Peripheral Vascular's YouTube channel, BD (33.8K subscribers). Click a video to play it here.
More on BD.
People of BARD Peripheral Vascular
1 people are tracked at BARD Peripheral Vascular (1 in leadership).
| Name | Role | Group |
|---|---|---|
Tim Ring | Chairman & CEO | Leadership |
Complete people profiles for BARD Peripheral Vascular
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Competitors of BARD Peripheral Vascular
BARD Peripheral Vascular operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Inari Medical, W. L. Gore & Associates, Contego Medical, Echopoint Medical and Limflow, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| inarimedical.com | 2011 | Irvine, United States | $51.89M | 696 | Catheter-based thrombectomy devices for vascular emboli removal are developed. | |
| gore.com | 1958 | Newark, United States | – | – | A portfolio of material science-based products is developed. | |
| contegomedical.com | 2005 | Raleigh, United States | $66.01M | – | Provider of vascular stenting with embolic protection for both coronary and peripheral vasculature | |
| echopointmedical.com | 2018 | London, United Kingdom | $9.74M | 8 | Smart devices for monitoring coronary artery disease are developed. | |
| limflow.com | 2012 | Paris, France | $97.45M | – | Developer a system for venous arterialization of the lower limbs | |
| angioscore.com | 2003 | Fremont, United States | $87M | – | Scoring balloon catheters for coronary and peripheral angioplasty are developed. | |
| vasc.com | 1997 | Minneapolis, United States | $12M | 562 | Products for vascular diagnostics and interventional procedures are developed. | |
| ev3.net | 2000 | Plymouth, United States | $58.8M | 1,307 | Surgical products for treatment of Peripheral vascular & Neurovascular diseases | |
| csi360.com | 1989 | Saint Paul, United States | $121.34M | 780 | Devices for treating peripheral and coronary vascular disease are developed. | |
| terumo.com | 1921 | Somerset, United States | – | – | Portfolio of medical devices for interventional cardiology is provided. |
Detailed competitors of BARD Peripheral Vascular
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of BARD Peripheral Vascular
The website of BARD Peripheral Vascular (bardpv.com) receives about 1.4K visits a month.
- Monthly visits1.4K
▲ 272.6% vs previous month
Websites whose visitors overlap most with BARD Peripheral Vascular. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| csi360.com | 99% | 2.6K | – | View details | |
| arrowintl.com | 83% | – | – | View details | |
| endologix.com | 82% | 5.4K | #2,329,965 | View details |
Similar companies to BARD Peripheral Vascular
10 companies that operate in the same segment as BARD Peripheral Vascular (Cardiac and Vascular Disorders), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Connected devices for health, sleep, and activity monitoring are developed. | 2008 | Moulineaux, Seine-maritime, France | USD 93.83 M | – | – | |
SMT is recognized as a developer of cardiovascular medical devices. | 1998 | Surat, Gujarat, India | USD 57.22 M | USD 106.25 M | 1,090 | |
Gene-editing therapies for coronary artery disease are developed. | 2018 | Cambridge, Massachusetts, United States | USD 215.5 M | – | 255 | |
Cardiac monitoring devices and applications are provided for heart health. | 2010 | Mountain View, California, United States | USD 114.38 M | USD 6.18 M | 67 | |
Therapies for lowering low-density lipoprotein cholesterol levels are developed. | 1998 | Ann Arbor, Michigan, United States | USD 129.7 M | USD 332.31 M | 304 | |
Cloud-based ambulatory ECG monitors for cardiac arrhythmia diagnosis are provided. | 2006 | San Francisco, California, United States | USD 109.23 M | USD 747.14 M | 2,000 | |
Provider of neuroprotection devices for carotid artery disease | 2007 | Sunnyvale, California, United States | USD 241.8 M | – | – | |
Miniaturized wireless implantable sensors are developed for hemodynamic monitoring. | 2007 | East Peoria, Illinois, United States | USD 154.77 M | – | 104 | |
Access catheters for neurovascular stroke treatment are provided. | 2015 | Campbell, California, United States | USD 596 M | – | – | |
Biosensor patches are developed for monitoring multiple body vitals. | 2011 | Campbell, California, United States | USD 239.95 M | – | 184 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about BARD Peripheral Vascular
BARD Peripheral Vascular was founded in 1974.
BARD Peripheral Vascular is headquartered in Tempe, United States. It is registered at Tempe, Arizona, United States.
Tim Ring is the current CEO of BARD Peripheral Vascular.
Bard Peripheral Vascular (Bard PV), formerly known as IMPRA, INC, and since 1974 operates as a subsidiary of C.R. Bard. Bard PV develops surgical and interventional devices for peripheral vascular single-patient-use medical products for hospital procedures. The company has establishments in United States, Puerto Rico, the United States Virgin Islands, and Canada. The products have applications in Vascular(angioplasty, venous catheters, stents stent grafts, valvuloplasty, vena cava filters, etc), Non-Vascular (biliary stents enteral feeding) and Biopsy (tissue markers, guide wires, probes, biopsy needles, etc). The company also offers services and support to surgeons, interventionalists, and radiologists. In Oct 2015, Acacia Research Units signed a Patent License Agreement with the company. In Dec 2015, Bard PV received a warning letter from FDA for misbranding and adulteration of IVC filters.
BARD Peripheral Vascular's top competitors include Inari Medical, W. L. Gore & Associates and Contego Medical.